[1]
Wardhani, S.O., Susanti, H. , Rahayu, P. , Yueniwati, Y. and Fajar, J. 2021. The Levels of FoxO3a Predict the Failure of Imatinib Mesylate Therapy among Chronic Myeloid Leukemia Patients. Open Access Macedonian Journal of Medical Sciences. 9, B (Apr. 2021), 255–259. DOI:https://doi.org/10.3889/oamjms.2021.5852.